Trial intelligence / Profile preview

Clascoterone Cream 1% in Facial Acneiform Rosacea

NCT06952517Phase 2Recruiting

Sponsor
Narrows Institute for Biomedical Research
Start
Mar 2025
Primary completion
Sep 2025
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of clascoterone in papulopustular rosacea, sponsored by Narrows Institute for Biomedical Research. Started Mar 2025; status: recruiting.

02

Drugs

clascoterone
03

Conditions

papulopustular rosacea

Beyond the preview

Go deeper on NCT06952517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06952517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call